Navigation Links
DuPont Responds to Spelter, W.Va. Lawsuit Rulings
Date:2/26/2008

Company Will Appeal to State Supreme Court

WILMINGTON, Del., Feb. 26 /PRNewswire-FirstCall/ -- The following statement is in response to the rulings in the Spelter, W.Va., zinc smelter class action lawsuit late Monday. The statement is to be attributed to DuPont General Counsel Stacey J. Mobley.

"We are extremely disappointed by the rulings in the Spelter case. DuPont will appeal this case, including the recent rulings and the earlier jury verdicts. We believe there were numerous errors, both during and after trial, that deprived the company of a fair outcome in this case. We are hopeful that the Supreme Court of Appeals of West Virginia will grant review.

"The scientific evidence simply does not warrant medical monitoring. We believe the evidence presented both at trial and in the post-trial proceedings shows that there is no increased risk of disease to the class members as a result of the smelter.

"The court's decision to include biennial chest CT scans in the medical monitoring program is particularly troubling. CT scans are not recommended for such medical monitoring because the risks of harm, including risks of cancer due to radiation exposure, outweigh any benefits. This determination is supported by a recent study published in the New England Journal of Medicine. The trial evidence showed that neither the U.S. Preventive Services Task Force, nor any other authoritative medical screening authority, recommends CT scans for screening asymptomatic patients. The court's rulings, which adopt a plan that includes regular CT scans, ignore the consensus of the medical community.

"The court also erred in estimating the cost of the medical monitoring program at $130 million. Plaintiffs' counsel presented a grossly inflated cost projection as justification for a larger award of attorneys' fees. This estimate is based on implausible and inflated assumptions and forecasts about medical costs and participation rates for the class members. This projection overestimates the reasonable expected cost of the program by many tens of millions of dollars. DuPont's funding obligations will be based on the actual cost of the program, not plaintiffs' unrealistic estimate."

DuPont (NYSE: DD) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DuPont Pledges $1 Million to World Food Prize
2. DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity
3. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
4. DuPont Announces Leadership Changes
5. DuPont Opens Fluoropolymer Production Plant in China
6. DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker
7. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
8. DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber
9. DuPont Names Phuong Tram Chief Information Officer
10. DuPont Group Vice President Briefs Investors on Performance Materials Segment
11. DuPont Responds to Spelter, W.Va., Lawsuit Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... Berkeley, and other leading institutions in announcing the launch of the Leadership ... the way animals are raised for food. , Founding members of the Leadership ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017   Divoti USA will engrave and ... standard of the latest FDA requirements, which stipulates new criteria regarding ... in need of Medical ID jewelry such as Medical ID Bracelets, ... engraved in terms of the new FDA requirements . ... Divoti offers this dark mark fiber ...
(Date:10/11/2017)... Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... facility in Las Piedras, Puerto Rico ... blades. Following ... facility sustained minor structural damage, temporary loss of power ... have been completed, manufacturing operations have resumed, and the ...
(Date:10/4/2017)... South Korea , Oct. 4, 2017  South ... its next-generation CPR training aide "cprCUBE" on Kickstarter. The ... chest compression during cardiac arrests with better efficiency compared ... It also offers real-time feedback on efficacy of the ... The crowdfunding campaign has a goal to raise $5,000. ...
Breaking Medicine Technology: